Cetera Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $259K | Buy |
10,760
+125
| +1% | +$3.01K | ﹤0.01% | 2045 |
|
|
2023
Q4 | $245K | Buy |
10,635
+210
| +2% | +$4.83K | ﹤0.01% | 1536 |
|
|
2023
Q3 | $212K | Buy |
10,425
+23
| +0.2% | +$468 | ﹤0.01% | 1511 |
|
|
2023
Q2 | $243K | Buy |
10,402
+3
| +0% | +$70 | ﹤0.01% | 1410 |
|
|
2023
Q1 | $242K | Sell |
10,399
-636
| -6% | -$14.8K | ﹤0.01% | 1397 |
|
|
2022
Q4 | $278K | Sell |
11,035
-710
| -6% | -$17.9K | 0.01% | 1277 |
|
|
2022
Q3 | $310K | Buy |
11,745
+1,218
| +12% | +$32.1K | 0.01% | 961 |
|
|
2022
Q2 | $304K | Buy |
+10,527
| New | +$304K | 0.01% | 1039 |
|